Toll-like receptor 9

A new target of ischemic preconditioning in the brain

Susan L. Stevens, Thomas M P Ciesielski, Brenda J. Marsh, Tao Yang, Delfina S. Homen, Jo Lynn Boule, Nikola S. Lessov, Roger P. Simon, Mary Stenzel-Poore

Research output: Contribution to journalArticle

127 Citations (Scopus)

Abstract

Preconditioning with lipopolysaccharide (LPS), a toll-like receptor 4 (TLR4) ligand, provides neuroprotection against subsequent cerebral ischemic brain injury, through a tumor necrosis factor (TNF)α-dependent process. Here, we report the first evidence that another TLR, TLR9, can induce neuroprotection. We show that the TLR9 ligand CpG oligodeoxynucleotide (ODN) can serve as a potent preconditioning stimulus and provide protection against ischemic brain injury. Our studies show that systemic administration of CpG ODN 1826 in advance of brain ischemia (middle cerebral artery occlusion (MCAO)) reduces ischemic damage up to 60% in a dose- and time-dependent manner. We also offer evidence that CpG ODN preconditioning can provide direct protection to cells of the central nervous system, as we have found marked neuroprotection in modeled ischemia in vitro. Finally, we show that CpG preconditioning significantly increases serum TNFα levels before MCAO and that TNFα is required for subsequent reduction in damage, as mice lacking TNFα are not protected against ischemic injury by CpG preconditioning. Our studies show that preconditioning with a TLR9 ligand induces neuroprotection against ischemic injury through a mechanism that shares common elements with LPS preconditioning via TLR4.

Original languageEnglish (US)
Pages (from-to)1040-1047
Number of pages8
JournalJournal of Cerebral Blood Flow and Metabolism
Volume28
Issue number5
DOIs
StatePublished - May 2008

Fingerprint

Toll-Like Receptor 9
Ischemic Preconditioning
Oligodeoxyribonucleotides
Tumor Necrosis Factor-alpha
Toll-Like Receptor 4
Middle Cerebral Artery Infarction
Brain
Ligands
Brain Injuries
Lipopolysaccharides
Cytoprotection
Wounds and Injuries
Brain Ischemia
Ischemia
Central Nervous System
Neuroprotection
Serum

Keywords

  • CpG
  • Ischemic tolerance
  • Neuroprotection
  • Preconditioning
  • TLR9

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)
  • Endocrinology, Diabetes and Metabolism

Cite this

Toll-like receptor 9 : A new target of ischemic preconditioning in the brain. / Stevens, Susan L.; Ciesielski, Thomas M P; Marsh, Brenda J.; Yang, Tao; Homen, Delfina S.; Boule, Jo Lynn; Lessov, Nikola S.; Simon, Roger P.; Stenzel-Poore, Mary.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 28, No. 5, 05.2008, p. 1040-1047.

Research output: Contribution to journalArticle

Stevens, SL, Ciesielski, TMP, Marsh, BJ, Yang, T, Homen, DS, Boule, JL, Lessov, NS, Simon, RP & Stenzel-Poore, M 2008, 'Toll-like receptor 9: A new target of ischemic preconditioning in the brain', Journal of Cerebral Blood Flow and Metabolism, vol. 28, no. 5, pp. 1040-1047. https://doi.org/10.1038/sj.jcbfm.9600606
Stevens, Susan L. ; Ciesielski, Thomas M P ; Marsh, Brenda J. ; Yang, Tao ; Homen, Delfina S. ; Boule, Jo Lynn ; Lessov, Nikola S. ; Simon, Roger P. ; Stenzel-Poore, Mary. / Toll-like receptor 9 : A new target of ischemic preconditioning in the brain. In: Journal of Cerebral Blood Flow and Metabolism. 2008 ; Vol. 28, No. 5. pp. 1040-1047.
@article{9e82857ac3f547de9b27581363dbd95c,
title = "Toll-like receptor 9: A new target of ischemic preconditioning in the brain",
abstract = "Preconditioning with lipopolysaccharide (LPS), a toll-like receptor 4 (TLR4) ligand, provides neuroprotection against subsequent cerebral ischemic brain injury, through a tumor necrosis factor (TNF)α-dependent process. Here, we report the first evidence that another TLR, TLR9, can induce neuroprotection. We show that the TLR9 ligand CpG oligodeoxynucleotide (ODN) can serve as a potent preconditioning stimulus and provide protection against ischemic brain injury. Our studies show that systemic administration of CpG ODN 1826 in advance of brain ischemia (middle cerebral artery occlusion (MCAO)) reduces ischemic damage up to 60{\%} in a dose- and time-dependent manner. We also offer evidence that CpG ODN preconditioning can provide direct protection to cells of the central nervous system, as we have found marked neuroprotection in modeled ischemia in vitro. Finally, we show that CpG preconditioning significantly increases serum TNFα levels before MCAO and that TNFα is required for subsequent reduction in damage, as mice lacking TNFα are not protected against ischemic injury by CpG preconditioning. Our studies show that preconditioning with a TLR9 ligand induces neuroprotection against ischemic injury through a mechanism that shares common elements with LPS preconditioning via TLR4.",
keywords = "CpG, Ischemic tolerance, Neuroprotection, Preconditioning, TLR9",
author = "Stevens, {Susan L.} and Ciesielski, {Thomas M P} and Marsh, {Brenda J.} and Tao Yang and Homen, {Delfina S.} and Boule, {Jo Lynn} and Lessov, {Nikola S.} and Simon, {Roger P.} and Mary Stenzel-Poore",
year = "2008",
month = "5",
doi = "10.1038/sj.jcbfm.9600606",
language = "English (US)",
volume = "28",
pages = "1040--1047",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Toll-like receptor 9

T2 - A new target of ischemic preconditioning in the brain

AU - Stevens, Susan L.

AU - Ciesielski, Thomas M P

AU - Marsh, Brenda J.

AU - Yang, Tao

AU - Homen, Delfina S.

AU - Boule, Jo Lynn

AU - Lessov, Nikola S.

AU - Simon, Roger P.

AU - Stenzel-Poore, Mary

PY - 2008/5

Y1 - 2008/5

N2 - Preconditioning with lipopolysaccharide (LPS), a toll-like receptor 4 (TLR4) ligand, provides neuroprotection against subsequent cerebral ischemic brain injury, through a tumor necrosis factor (TNF)α-dependent process. Here, we report the first evidence that another TLR, TLR9, can induce neuroprotection. We show that the TLR9 ligand CpG oligodeoxynucleotide (ODN) can serve as a potent preconditioning stimulus and provide protection against ischemic brain injury. Our studies show that systemic administration of CpG ODN 1826 in advance of brain ischemia (middle cerebral artery occlusion (MCAO)) reduces ischemic damage up to 60% in a dose- and time-dependent manner. We also offer evidence that CpG ODN preconditioning can provide direct protection to cells of the central nervous system, as we have found marked neuroprotection in modeled ischemia in vitro. Finally, we show that CpG preconditioning significantly increases serum TNFα levels before MCAO and that TNFα is required for subsequent reduction in damage, as mice lacking TNFα are not protected against ischemic injury by CpG preconditioning. Our studies show that preconditioning with a TLR9 ligand induces neuroprotection against ischemic injury through a mechanism that shares common elements with LPS preconditioning via TLR4.

AB - Preconditioning with lipopolysaccharide (LPS), a toll-like receptor 4 (TLR4) ligand, provides neuroprotection against subsequent cerebral ischemic brain injury, through a tumor necrosis factor (TNF)α-dependent process. Here, we report the first evidence that another TLR, TLR9, can induce neuroprotection. We show that the TLR9 ligand CpG oligodeoxynucleotide (ODN) can serve as a potent preconditioning stimulus and provide protection against ischemic brain injury. Our studies show that systemic administration of CpG ODN 1826 in advance of brain ischemia (middle cerebral artery occlusion (MCAO)) reduces ischemic damage up to 60% in a dose- and time-dependent manner. We also offer evidence that CpG ODN preconditioning can provide direct protection to cells of the central nervous system, as we have found marked neuroprotection in modeled ischemia in vitro. Finally, we show that CpG preconditioning significantly increases serum TNFα levels before MCAO and that TNFα is required for subsequent reduction in damage, as mice lacking TNFα are not protected against ischemic injury by CpG preconditioning. Our studies show that preconditioning with a TLR9 ligand induces neuroprotection against ischemic injury through a mechanism that shares common elements with LPS preconditioning via TLR4.

KW - CpG

KW - Ischemic tolerance

KW - Neuroprotection

KW - Preconditioning

KW - TLR9

UR - http://www.scopus.com/inward/record.url?scp=42549149695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42549149695&partnerID=8YFLogxK

U2 - 10.1038/sj.jcbfm.9600606

DO - 10.1038/sj.jcbfm.9600606

M3 - Article

VL - 28

SP - 1040

EP - 1047

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 5

ER -